AFLIVISIO Trademark

Trademark Overview

On Tuesday, December 6, 2022, a trademark application was filed for AFLIVISIO with the United States Patent and Trademark Office. The USPTO has given the AFLIVISIO trademark a serial number of 79359542. The federal status of this trademark filing is REGISTERED as of Tuesday, May 7, 2024. This trademark is owned by Klinge Biopharma GmbH. The AFLIVISIO trademark is filed in the Pharmaceutical Products category with the following description:

Medicines and pharmaceutical preparations for human medical use, other than for dermatological purposes, in particular ophthalmological preparations for the treatment of eye diseases and ailments; medical plasters, other than for cosmetic purposes, and medical dressing materials and disinfectants, other than for dermatological purposes and for the skin
aflivisio

General Information

Serial Number79359542
Word MarkAFLIVISIO
Filing DateTuesday, December 6, 2022
Status700 - REGISTERED
Status DateTuesday, May 7, 2024
Registration Number7376537
Registration DateTuesday, May 7, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 20, 2024

Trademark Statements

Goods and ServicesMedicines and pharmaceutical preparations for human medical use, other than for dermatological purposes, in particular ophthalmological preparations for the treatment of eye diseases and ailments; medical plasters, other than for cosmetic purposes, and medical dressing materials and disinfectants, other than for dermatological purposes and for the skin

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 6, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKlinge Biopharma GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameKlinge Biopharma GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameKlinge Biopharma GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Thursday, January 5, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, January 6, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 10, 2023APPLICATION FILING RECEIPT MAILED
Wednesday, September 13, 2023ASSIGNED TO EXAMINER
Wednesday, September 13, 2023NON-FINAL ACTION WRITTEN
Thursday, September 14, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, October 10, 2023REFUSAL PROCESSED BY MPU
Tuesday, October 10, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, November 1, 2023REFUSAL PROCESSED BY IB
Saturday, January 13, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, January 13, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, January 13, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 15, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 1, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 1, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 7, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Thursday, February 1, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 1, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 7, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, February 20, 2024PUBLISHED FOR OPPOSITION
Monday, February 26, 2024NOTIFICATION PROCESSED BY IB
Monday, March 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, August 7, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 7, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, May 7, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sunday, May 26, 2024NEW REPRESENTATIVE AT IB RECEIVED
Saturday, November 2, 2024FINAL DISPOSITION PROCESSED
Saturday, November 2, 2024FINAL DISPOSITION NOTICE SENT TO IB
Saturday, November 23, 2024FINAL DECISION TRANSACTION PROCESSED BY IB

Related Keywords

aflivisio other purposes medical than dermatological preparations cosmetic plasters dressing skin